Vaxart, Inc.
VXRT
$0.48
-$0.02-4.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 243.06M | 255.61M | 237.26M | 148.20M | 80.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 243.06M | 255.61M | 237.26M | 148.20M | 80.72M |
| Cost of Revenue | 184.26M | 200.25M | 201.58M | 179.08M | 118.20M |
| Gross Profit | 58.80M | 55.36M | 35.68M | -30.88M | -37.48M |
| SG&A Expenses | 19.19M | 17.18M | 17.61M | 17.97M | 18.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 203.45M | 217.43M | 219.18M | 197.05M | 136.23M |
| Operating Income | 39.61M | 38.18M | 18.07M | -48.84M | -55.51M |
| Income Before Tax | 39.01M | 37.51M | 16.80M | -50.40M | -56.33M |
| Income Tax Expenses | 419.00K | 410.00K | 476.00K | 308.00K | 309.00K |
| Earnings from Continuing Operations | 38.59 | 37.10 | 16.33 | -50.70 | -56.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.59M | 37.10M | 16.33M | -50.70M | -56.64M |
| EBIT | 39.61M | 38.18M | 18.07M | -48.84M | -55.51M |
| EBITDA | 45.62M | 45.64M | 26.65M | -40.08M | -46.60M |
| EPS Basic | 0.16 | 0.15 | 0.06 | -0.22 | -0.25 |
| Normalized Basic EPS | 0.10 | 0.10 | 0.04 | -0.14 | -0.15 |
| EPS Diluted | 0.16 | 0.15 | 0.06 | -0.22 | -0.25 |
| Normalized Diluted EPS | 0.10 | 0.10 | 0.04 | -0.14 | -0.15 |
| Average Basic Shares Outstanding | 947.60M | 933.80M | 921.08M | 912.80M | 911.33M |
| Average Diluted Shares Outstanding | 949.44M | 935.65M | 921.38M | 912.80M | 911.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |